Japan stocks set to dip as hopes of coronavirus treatment reportedly take a hit

Investors will watch for market reaction to an overnight report by the Financial Times — citing documents accidentally published by the World Health Organization — that Gilead Sciences' drug remdesivir did not improve coronavirus patients' condition. The documents cited by the FT referred to a Chinese clinical trial.

Stocks in Japan were set to decline at the Friday open after an overnight report that raised doubts over a potential coronavirus treatment. The Nikkei futures contract in Chicago was at 19,385 while its counterpart in Osaka was at 19,370. That compared against theMeanwhile, shares in Australia were poised for a muted open, with the SPI futures contract at 5,218, as compared to the S&P/ASX 200's last close at 5,217.10.

Why would anyone believe anything coming out of the WHO?

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

In Japan, Mythical 'Amabie' Emerges From 19th Century Folklore To Fight COVID-19The sea monster from folklore has emerged in art, food and fashion as a symbol of hope and pop culture mascot. Its first depiction was in 1846, telling people to draw it and 'be free from disease.' Cute - their mermaids are much more reserved than ours😂 He claims he will 'banish germs to the land of wind and ghosts.' I-Is this the original image?
Source: NPRHealth - 🏆 144. / 63 Read more »